成像市場：按技術、按應用、按最終用戶、按影像類型、按地區

成像市場規模預計將從 2023 年的 376.3 億美元增加到 2030 年的 565.8 億美元，預測期內年複合成長率為 6%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	376.3億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	6.00%	2030年市場規模預測	565.8億美元

圖 1. 2023 年按地區分類的成像全球市場佔有率(%)

成像是醫療圖像的一個領域，可以視覺化大腦的結構和功能。它提供了對各種疾病和病症背後的神經過程和異常的寶貴見解。這項技術徹底改變了神經科學領域，並為我們對人類大腦的理解做出了重大貢獻。

市場動態：

成像市場由多種因素驅動。首先，神經系統疾病的日益普及增加了對準確診斷工具的需求，從而導致了神經影像成像技術的採用。此外，磁振造影（MRI）、正子斷層掃描（PET）和電腦斷層掃描（CT）等影像技術的進步顯著提高了腦部影像的解析度和準確性。影像設備的高成本以及相關的維護和運作成本限制了其可近性，特別是在發展中地區。此外，對某些影像方式（例如電腦斷層掃描中的電離輻射暴露）安全性的擔憂對市場成長構成了挑戰。儘管如此，成像市場仍存在一些機會。增加對研發活動的投資，以開發功能性磁振造影（fMRI）和擴散張量影像（DTI）等先進影像技術，預計將推動市場成長。此外，對個人化醫療的日益關注以及人工智慧（AI）在成像中的整合為市場擴張提供了新的途徑。

本研究的主要特點

• 本報告對全球成像市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（年複合成長率%）。
• 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球成像市場的主要企業。
• 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
• 全球成像市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球成像市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 調查目的和假設

• 這項研究的目的
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
  • 影像技術的進步
  • 設備成本高
  • 個人化醫療
• 影響分析
• 主要亮點
• 法規場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章 成像市場－冠狀病毒（COVID-19）大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章 成像市場，依技術分類，2023-2030 年

• 磁振造影(MRI)
• 電腦斷層掃描 (CT)
• 正子斷層掃描 (PET)
• 單光子發射電腦斷層掃描 (SPECT)
• 功能性磁振造影(fMRI)
• 擴散張量成像(DTI)
• 腦磁圖（MEG）
• 腦電圖（EEG）
• 其他

第6章 成像市場，依應用分類，2023-2030

• 神經系統疾病
• 阿茲海默症
• 帕金森氏症
• 多發性硬化症
• 癲癇
• 中風
• 其他
• 精神障礙
• 思覺失調症
• 躁鬱症
• 沮喪
• 焦慮症
• 其他
• 創傷性腦損傷 (TBI)
• 腦腫瘤
• 其他

第7章 成像市場，依最終使用者分類，2023-2030 年

• 醫院和診所
• 醫院和診所
• 調查機構
• 門診手術中心
• 其他

第8章 成像市場，依影像類型，2023-2030

• 構造成像
• 功能性成像
• 混合成像

第9章 成像市場，按地區，2023-2030

• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲

第10章 競爭形勢

• GE Healthcare
• Philips Healthcare
• Toshiba Medical Systems Corporation
• Hitachi Healthcare
• Canon Medical Systems Corporation
• Mindray Medical International Limited
• Esaote SpA
• NeuroLogica Corporation
• Others

第11章章節

• 調查方法
• 關於出版商

The Neuroimaging Market size is expected to reach US$ 56.58 Billion by 2030, from US$ 37.63 Billion in 2023, at a CAGR of 6% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 37.63 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.00%	2030 Value Projection:	US$ 56.58 Bn

Figure 1. Global Neuroimaging Market Share (%), By Region, 2023

Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underlie various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.

Market Dynamics:

The neuroimaging market is driven by several factors. Firstly, the growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.

However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Additionally, concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.

Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Moreover, the rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.

Key features of the study:

• This report provides in-depth analysis of the global neuroimaging market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroimaging market

Detailed Segmentation:

• By Technology:
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Functional Magnetic Resonance Imaging (fMRI)
  • Diffusion Tensor Imaging (DTI)
  • Magnetoencephalography (MEG)
  • Electroencephalography (EEG)
  • Others
• By Application:
  • Neurological Disorders
  • Alzheimer's Disease
  • Parkinson's Disease
  • Multiple Sclerosis
  • Epilepsy
  • Stroke
  • Others
  • Psychiatric Disorders
  • Schizophrenia
  • Bipolar Disorder
  • Depression
  • Anxiety Disorders
  • Others
  • Traumatic Brain Injury (TBI)
  • Brain Tumors
  • Others
• By End-User:
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Institutes
  • Ambulatory Surgical Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
• By Image Type:
  • Structural Imaging
  • Functional Imaging
  • Hybrid Imaging
• Top companies in Neuroimaging Market
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi Healthcare
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • Esaote SpA
  • NeuroLogica Corporation
  • NeuroVive Pharmaceutical AG
  • Brainlab AG
  • Akili Interactive Labs Inc.
  • Brainomix Ltd.
  • Imaging Science International
  • Mevis Medical Solutions
  • NeuroVista
  • Neusoft Medical Systems
  • Positron Corporation
  • Shimadzu Corporation
  • Trifoil Imaging

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Image Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Advancements in Imaging Technology
  • High Equipment Costs
  • Personalized Medicine
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Neuroimaging Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Neuroimaging Market , By Technology, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Magnetic Resonance Imaging (MRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Computed Tomography (CT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Positron Emission Tomography (PET)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Single Photon Emission Computed Tomography (SPECT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Functional Magnetic Resonance Imaging (fMRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Diffusion Tensor Imaging (DTI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Magnetoencephalography (MEG)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Electroencephalography (EEG)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Neuroimaging Market , By Application, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Epilepsy
• Stroke
• Others
• Psychiatric Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Schizophrenia
• Bipolar Disorder
• Depression
• Anxiety Disorders
• Others
• Traumatic Brain Injury (TBI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Brain Tumors
• Others

7. Neuroimaging Market , By End User, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Neuroimaging Market , By Image Type, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Structural Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Functional Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
• Hybrid Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Neuroimaging Market , By Region, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2018 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)

10. Competitive Landscape

• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Philips Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Toshiba Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hitachi Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Canon Medical Systems Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mindray Medical International Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Esaote SpA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NeuroLogica Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Others
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us